Onconetix Inc.

Onconetix Inc. is a commercial-stage biotechnology company focused on solutions for men’s health and oncology. The company develops and commercializes proprietary therapeutics, diagnostics, and clinician-focused services, with an emphasis on prostate cancer and related urologic conditions. Its product portfolio includes Proclarix, a blood-based diagnostic test used in prostate cancer assessment, and Entadfi, an oral therapy for benign prostatic hyperplasia. Onconetix also works on expanding its oncology diagnostics and treatment offerings through research, development, and commercialization activities across key international markets, including the United States and Europe. Headquartered in Cincinnati, Ohio, Onconetix Inc. operates at the intersection of diagnostic testing and therapeutic care, serving healthcare providers and patients in specialized cancer and men’s health settings.

Sector

Healthcare

Industry

Biotechnology

CEO

Ms. Karina M. Fedasz

Employees

2

Headquarters

Cincinnati, OH, United States

Website

www.onconetix.com